Evaluating Implementation and Scale-Up of Nigeria's National Sodium Reduction Program
Washington University School of Medicine
1,350 participants
Jun 26, 2023
OBSERVATIONAL
Conditions
Summary
The NaSS aims to assess the extent to which the SHAKE program is implemented within Nigeria by the Nigerian Agency for Food and Drug Administration and Control (NAFDAC) using a type III hybrid, mixed method study design.
Eligibility
Inclusion Criteria4
- Male and female adults (aged 18 to 69 years)
- Willingness to participate
- Permanent residents (a person who has been in the household for at least 6 months) of the study area
- Ability to provide informed consent
Exclusion Criteria8
- Individuals who are unable to provide informed consent
- Pregnant women, and those who are breastfeeding and/or women menstruating at the time of collection
- Cognitively impaired adults
- Those with known history of heart or kidney failure, stroke, liver disease
- Those who recently began therapy with diuretics (less than two weeks)
- Any other conditions that would make 24-hour urine collection difficult
- Individuals who are not yet adults (minors): i.e. infants, children, or teenagers <18 years old
- Prisoners or other detained individuals
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
The SHAKE (Surveillance of salt intake, Harness industry, Adopt standards for labelling and marketing, Knowledge to empower consumers, and Environments to promote health eating) package is a WHO Best Buy and is recently implemented within Nigeria by the Nigerian Agency for Food and Drug Administration and Control (NAFDAC).
Locations(3)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT04765865